Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1995
03/01/1995EP0640606A1 Thienopyrimidine derivatives, their production and use
03/01/1995EP0640599A1 4-Aminopyrimidine derivatives
03/01/1995EP0640596A1 N-pyridazinyl-benzene (naphthalene-, biphenyl-) sulfonamide derivatives, their preparation and their use as endothelin antagonists
03/01/1995EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them
03/01/1995EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists
03/01/1995EP0640590A1 Process for the synthesis of 4-mercaptophenols and naphthalenols
03/01/1995EP0640588A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
03/01/1995EP0640587A1 Diacyl substituted guanidins, process for their preparation, their use as medicament or diagnostic reagent and medicament containing them
03/01/1995EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions
03/01/1995EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
03/01/1995EP0640084A1 6-AMINO SUBSTITUTED IMIDAZO 4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS
03/01/1995EP0640082A1 Heteroaromatic quinuclidinenes, their use and preparation
03/01/1995EP0640078A1 Nitric 1,2-benzo-isothiazolyl-3(2h)one-1,1-dioxide esters, preparation method therefor and drugs containing same
03/01/1995EP0639981A1 Igf-1 analogs
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0639973A1 Diamines in the treatment of arrhythmia
03/01/1995EP0518908B1 Method for polymerization of epoxide compounds
03/01/1995EP0462264B1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists
03/01/1995CN1099392A Compounds containing a fused bicyclic ring and processes therefor
03/01/1995CA2130971A1 Sulfonamide endothelin antagonists
02/1995
02/28/1995US5393875 Amino acid derivatives having renin inhibiting activity
02/28/1995US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism
02/28/1995US5393786 Administering certain phenolic compounds
02/28/1995US5393779 Anti-obesity, hypoglycemic, adrenergic blocking agents
02/28/1995US5393775 Benzopyran compounds
02/28/1995US5393773 Method for the intranasal administration of 3-[2-(dimethylamino)-ethyl]-H-methyl-1H-indole-5-methanesulphonamide
02/28/1995US5393772 Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation
02/28/1995US5393771 4-substituted benzopyran and related compounds
02/28/1995US5393755 Polycyclic guanine derivatives
02/28/1995US5393747 Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists
02/28/1995US5393740 Neurotensin Hexapeptides
02/28/1995CA1334591C 1,4-dihydropyridine carboxylic acid ester derivatives, processes for their preparation and pharmaceutical compositions containing same
02/27/1995CA2130859A1 Thienopyrimidine derivatives, their production and use
02/26/1995CA2130615A1 Methods of inhibiting vascular restenosis
02/23/1995WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides
02/23/1995WO1995005383A1 Vasocontrictive dihydrobenzopyran derivatives
02/23/1995WO1995005381A1 Vasoconstrictive substituted dihydropyranopyridines
02/23/1995WO1995005376A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists
02/23/1995WO1995005366A1 Vasoconstrictive substituted aryloxyalkyl diamines
02/23/1995WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995WO1995005360A1 Phenoxyphenyl cyclopentenyl hydroxyureas
02/23/1995WO1995005358A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect
02/23/1995WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY
02/23/1995WO1995005180A1 Methods and compositions for inhibiting uridine secretion
02/23/1995CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity
02/23/1995CA2169280A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995CA2169187A1 Use of phenols and phenol derivatives as pharmaceutical agents with a fibrinogen-lowering action
02/23/1995CA2165567A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelien antagonists
02/23/1995CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides
02/22/1995EP0639586A1 Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them
02/22/1995EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production
02/22/1995EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it
02/22/1995EP0639552A1 Napthalenederivatives, their preparation and pharmaceutical compositions containing them
02/22/1995EP0639191A1 Indazol-3-one-2-yl derivatives of benzopyrans.
02/22/1995EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
02/22/1995EP0639076A1 Use of guanylate cyclase inhibitors in the treatment of shock
02/22/1995EP0639074A1 Anti-ischemic medicament
02/22/1995CN1099040A Linear adhesion inhibitor
02/22/1995CN1099032A Derivative of benzoxazine, preparation and pharmaceutical application of same
02/22/1995CN1098907A Dry mix formulation for bisphosphonic acids
02/21/1995US5391758 Heterocyclic amide derivatives
02/21/1995US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses
02/21/1995US5391751 Hypotensive, antiarrhythmia, antiasthmatic agents
02/21/1995US5391731 Pyrroloazepine derivatives
02/21/1995US5391576 Method for treating and protecting the cerebral tissue against repercussions of cerebral ischaemia and cerebral infarctions
02/21/1995US5391565 Oxazolidine dione derivatives
02/21/1995US5391559 Antiischemic agents; antihypoxic agents; antiedemic agents
02/21/1995US5391495 Using enzyme or microorganism catalyst
02/19/1995CA2129906A1 Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them
02/16/1995WO1995004829A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein
02/16/1995WO1995004755A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
02/16/1995WO1995004752A1 Therapeutic peptide derivatives
02/16/1995WO1995004737A1 Condensed indole derivatives as 5-ht4-receptor antagonists
02/16/1995WO1995004734A1 Hydroisoquinoline derivatives
02/16/1995WO1995004730A1 Benzopyrans and pharmaceutical compositions containing them
02/16/1995WO1995004534A1 Endothelin receptor antagonists
02/16/1995WO1995004530A1 Endothelin receptor antagonists
02/16/1995CA2168853A1 Hydroisoquinoline derivatives
02/16/1995CA2168750A1 Condensed indole derivatives as 5-ht4-receptor antagonists
02/16/1995CA2167489A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein
02/16/1995CA2145767A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
02/15/1995EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them
02/15/1995EP0638556A1 Medicaments containing 1-Thiocarbamoyl-5-hydroxy pyrazoles and their use as agents for the treatment of septic shock
02/15/1995EP0638553A1 Carboxylic acid amides having a terminal carboxylic acid group as aggregation inhibiting drugs
02/15/1995EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
02/15/1995EP0638126A1 Inhibitory factor
02/15/1995EP0638084A1 Substituted phosphonates, the processes for their preparation and pharmaceutical compositions containing them
02/15/1995EP0638061A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
02/15/1995EP0637959A1 Soluble analogs of probucol
02/15/1995EP0540544B1 Benzoic acid substituted derivatives having cardiovascular activity
02/15/1995EP0423366B1 Phospholipid derivatives
02/15/1995EP0394484B1 Benzothiadiazepine derivatives
02/15/1995EP0339046B1 Leukotriene b 4 analogs
02/15/1995CN1098721A Condensed quinolyl-dihydropyridines, processes for their preparation and their use in medicaments
02/15/1995CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors
02/15/1995CN1098648A "Xiaofengtong" injection and its manufacturing method
02/15/1995CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives
02/14/1995US5389684 Naphthalene carboxamides
02/14/1995US5389675 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
02/14/1995US5389666 Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension
1 ... 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 ... 1595